Procter & Gamble Health is a focused Indian pharmaceutical company that treats widespread, everyday nutritional deficiencies - nerve weakness, iron shortage, liver trouble - with a stable of household-name vitamin brands. It was built on a five-decade heritage as Merck Limited before the global consumer-goods giant Procter & Gamble acquired it in 2018, giving it the corporate backing of one of the world’s largest health and hygiene groups. The recurring approach is to take a single, well-understood health problem, back it with a doctor-recommended brand, and then widen the brand’s reach by moving it from the chemist’s prescription counter into the consumer’s daily life - through new formats like gummies, new channels like quick-commerce, and new geographies in India’s smaller towns.
Business segments
Two engines that feed the same patient - a branded pharmaceuticals business that sells through doctors and chemists, and a consumer-health business that sells the same science through e-commerce and retail shelves - both drawing from one portfolio of VMS brands.
1. Branded pharmaceuticals: the doctor-recommended core
The company’s foundation is a set of prescription-led vitamin and mineral brands that dominate their niches because doctors have trusted them for decades.
- India’s most-prescribed iron supplement - Livogen is the country’s number-one doctor-recommended iron brand, a position built on a formulation of ferrous fumarate, folic acid and zinc sulphate that addresses the 37% of Indians estimated to be iron-deficient.
- A fifty-year nerve-health franchise - Neurobion Forte has been treating body discomfort from Vitamin B deficiency for over half a century, and the range has been extended with variants like Neurobion Alfa D specifically for diabetic nerve damage.
- The liquid B-complex leader - Polybion is the number-one B-complex liquid brand, with a sugar-free syrup enriched with the amino acid lysine that turns a clinical supplement into something children will actually take.
- A medical sales force that builds the prescription funnel - a trained field force works directly with healthcare practitioners and healthcare organisations, running in-clinic education and partnering with bodies like the Federation of Obstetric and Gynaecological Societies of India to keep the brands top-of-mind at the point of diagnosis.
- Injections sourced, not made - the company stopped manufacturing its injections portfolio at its Goa plant in September 2023 and now buys it from a contract manufacturer, freeing up plant capacity while keeping the product line alive in the market.
2. Consumer health: taking the same brands beyond the prescription
The company is pulling its pharmaceutical brands into the over-the-counter and everyday-nutrition world, where growth comes from new formats, new shoppers and new shelves.
- Gummies for the reluctant patient - Livogen Iron Gummies in strawberry flavour turn iron supplementation into a tasty daily habit, targeting tiredness and weakness in a form that needs no doctor’s push.
- A nerve-pain cream that skips the pill - Neurobion Nerve Pain Relief Cream delivers capsaicin directly to the skin for burning and tingling sensations, creating a consumer-health entry point for a franchise that was historically tablet-only.
- E-pharmacies and quick-commerce as the new chemist shop - the company treats e-commerce as a material, fast-growing channel, with brands like Livogen earning “Amazon’s Choice” badges and listings designed for the shopper who buys health products the way they buy groceries.
- Television and digital built the consumer voice - the company put Evion, Livogen and Polybion on air for the first time in FY21, then layered on OTT and digital campaigns, cricket tie-ups and in-serial integrations for Nasivion, so that patients start asking for the brand rather than just accepting the prescription.
- An extra-urban push into white space - over the last two to three years, the company added nearly 30,000 pharmacies and healthcare practitioners to its coverage, deliberately expanding beyond metro cities into towns where nutritional deficiencies are high but branded VMS penetration is low.
Group structure and partners
The company is a standalone Indian listed entity with no subsidiaries or debt, operating inside the global Procter & Gamble machine.
- Ultimate parent is the American giant - Procter & Gamble Health is a subsidiary of The Procter & Gamble Company, USA, with the immediate holding company being Procter & Gamble Overseas India B.V. in the Netherlands, which held just over 51% of the shares.
- Global technology, local application - the company draws on continuous product-development and process upgrades from its US parent and its subsidiaries, which management calls an unmatched competitive advantage in quality, cost and energy efficiency.
- No borrowings, no subsidiaries - the company operates on a standalone basis with zero debt, no joint ventures and no associates, funding its own growth and returning cash without external leverage.
- Governance aligned to the parent’s manual - a Governance Board of the managing director, CFO and other functional heads assesses enterprise risk under a policy aligned with P&G’s global guidelines, and the company operates under the parent’s Worldwide Business Conduct Manual.